Supha Pharmachem (BOM:539561) Marketable Securities: ₹10 Mil (As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:539561 Supha Pharmachem Ltd BOM:539561
55 GF Score
Price ₹0.27
GF Value ₹1.51
Valuation Possible Value Trap
! 12 Warning Signs
View Full Analysis

What is Supha Pharmachem Marketable Securities?

Supha Pharmachem BOM:539561 55 Marketable Securities is ₹10 Mil as of Sep. 2025. GuruFocus rates BOM:539561 with a GF Score™ of 55/100 and a GF Value™ of ₹1.51 (Possible Value Trap). The stock has 12 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Supha Pharmachem's Marketable Securities for the quarter that ended in Sep. 2025 was ₹10 Mil.

Supha Pharmachem's annual Marketable Securities declined from Mar. 2023 (₹216 Mil) to Mar. 2024 (₹13 Mil) but then increased from Mar. 2024 (₹13 Mil) to Mar. 2025 (₹15 Mil).

Supha Pharmachem  (BOM:539561) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Supha Pharmachem Marketable Securities Related Terms

Supha Pharmachem Marketable Securities Historical Data

* Premium members only.

The historical data trend for Supha Pharmachem's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Supha Pharmachem Marketable Securities Chart

Supha Pharmachem Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.48 7.38 216.12 12.78 15.40

Supha Pharmachem Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 48.32 0.00 15.40 0.00 10.34
BOM:539561
55GF Score
Supha Pharmachem Ltd BOM:539561
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Supha Pharmachem Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ₹10 Mil mean?
Supha Pharmachem (BOM:539561) has a Marketable Securities of ₹10 Mil as of Sep. 2025. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Supha Pharmachem and its competitors.
Is Supha Pharmachem's Marketable Securities too high?
Supha Pharmachem's current Marketable Securities is ₹10 Mil. Overall, Supha Pharmachem has a GF Score™ of 55/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Supha Pharmachem's Marketable Securities compare to ZTS?
Supha Pharmachem's Marketable Securities of ₹10 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Drug Manufacturers company?
A good Marketable Securities depends on the Drug Manufacturers industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Supha Pharmachem and its competitors. Supha Pharmachem's current Marketable Securities is ₹10 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Supha Pharmachem stock overvalued right now?
Based on GuruFocus' analysis, Supha Pharmachem (BOM:539561) is currently considered Possible Value Trap. The stock's GF Value™ is ₹1.51, compared to a current price of ₹0.27 — trading 82.1% below its estimated fair value. The current Marketable Securities is ₹10 Mil. Supha Pharmachem's overall GF Score™ is 55/100 with 12 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Supha Pharmachem (BOM:539561), the current Marketable Securities is ₹10 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Supha Pharmachem (BOM:539561) Overvalued in 2026?

Based on GuruFocus' analysis, Supha Pharmachem stock appears to be undervalued. The current stock price of ₹0.27 is trading 82.1% below its estimated GF Value™ of ₹1.51. GuruFocus considers Supha Pharmachem to be Possible Value Trap.

Key valuation signals for BOM:539561:

  • Marketable Securities: ₹10 Mil
  • GF Value™: ₹1.51 vs. price of ₹0.27 (82.1% below fair value)
  • GF Score™: 55/100 with 12 warning signs

No single metric tells the full story. See the BOM:539561 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Supha Pharmachem Business Description

Address Saugbaug Road, Office No. 9, Behind Ravi Vihar Hotel, K Raheja Prime, Marol Industrial Estate, Andheri (East), Mumbai, MH, IND, 400059
Supha Pharmachem Ltd, formerly known as Remedium Lifecare Ltd, is engaged in the business of trading in API Intermediates (KSMs & CRMs) and various other raw materials used in API trading viz. Iso propyl Alcohol (IPA), Cyclohexane, DI Iso Propyl Amine (DIPA), Ethyl Acetate, Hydrazine Hydrate, Iso propyl Alcohol (IPA), Methylene Di Chloride, Potassium Carbonate Powder, Sodium Bi-Carbonate, Potassium Hydroxide Flakes, Sodium Chloride (Common Salt), Sodium Carbonate (SODA ASH), Amino isophthalic Acid, Tellurium(IV) Oxide, Grignard Reagent, Iodine, Selenium Metal Powder, Trimethyl Sulfoxonium Iodide (TMSI).
55GF Score

Get the complete analysis for BOM:539561

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹0.27
Price
₹1.51
GF Value